China NMPA Product Recall - Thyroxine Binding Ability Assay Kit

Abbott Laboratories, through its distributor Abbott Trading (Shanghai) Co., Ltd., initiated a voluntary Class III recall of its Thyroxine Binding Ability Assay Kit (Registration Certificate No.: 20162404544). Published by the National Medical Products Administration (NMPA) on July 21, 2017, this action was taken due to identified issues involving potential calibration failures or problems with the curve validity check within the assay kits. The manufacturer proactively undertook this recall to uphold product reliability and ensure patient safety. A Class III recall typically indicates that the use of the affected product is not likely to cause adverse health consequences, but it still deviates from quality standards. Detailed information regarding affected product models, specifications, and batch numbers was provided in a "Medical Device Recall List" and an accompanying "Medical Device Recall Event Report Form." This voluntary measure highlights Abbott's dedication to product quality and adherence to NMPA's regulatory framework, addressing the identified performance anomalies in its diagnostic kits.